BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao Y, Zhu X, Hossen MN, Kakar P, Zhao Y, Chen X. Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant. Nat Commun 2018;9:3695. [PMID: 30209303 DOI: 10.1038/s41467-018-06151-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kang X, Li Y, Zhao Y, Chen X. Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant. Vaccines 2022;10:1894. [DOI: 10.3390/vaccines10111894] [Reference Citation Analysis]
2 Khare S, Niharika, Singh A, Hussain I, Singh NB, Singh S. SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders. Appl Biochem Biotechnol 2022. [PMID: 36222988 DOI: 10.1007/s12010-022-04181-3] [Reference Citation Analysis]
3 Li L, Liang X, He T, Li X, Huang X, Wang N, Shen M, Shu Y, Wu R, Zhang M, Wu Q, Gong C. Multifunctional light-activatable nanocomplex conducting temperate-heat photothermal therapy to avert excessive inflammation and trigger augmented immunotherapy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121815] [Reference Citation Analysis]
4 Xue W, Li T, Zhang S, Wang Y, Hong M, Cui L, Wang H, Zhang Y, Chen T, Zhu R, Chen Z, Zhou L, Zhang R, Cheng T, Zheng Q, Zhang J, Gu Y, Xia N, Li S. Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice. Viruses 2022;14:1785. [DOI: 10.3390/v14081785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhao Y, Li Z, Voyer J, Li Y, Chen X. Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development. ACS Appl Mater Interfaces 2022;14:21872-85. [PMID: 35467839 DOI: 10.1021/acsami.2c01028] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Li Z, Kim KH, Bhatnagar N, Park BR, Jeeva S, Jung YJ, Raha J, Kang SM, Chen X. Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination. FASEB J 2022;36:e22182. [PMID: 35113455 DOI: 10.1096/fj.202101703R] [Reference Citation Analysis]
7 Li Y, Li Z, Zhao Y, Chen X. Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant. Vaccines (Basel) 2021;9:1382. [PMID: 34960128 DOI: 10.3390/vaccines9121382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barghash RF, Fawzy IM, Chandrasekar V, Singh AV, Katha U, Mandour AA. In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19. Coatings 2021;11:1273. [DOI: 10.3390/coatings11111273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wang YX, Yang GH, Zhang LL, Wang J, Wang JF. Melatonin as Immune Potentiator for Enhancing Subunit Vaccine Efficacy against Bovine Viral Diarrhea Virus. Vaccines (Basel) 2021;9:1039. [PMID: 34579276 DOI: 10.3390/vaccines9091039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Immunological considerations and vaccines against COVID-19. Biomed Lett 2021;7:54-62. [DOI: 10.47262/bl/7.1.20210501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ; AASLD COVID-19 Vaccine Working Group. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. Hepatology 2021;74:1049-64. [PMID: 33577086 DOI: 10.1002/hep.31751] [Cited by in Crossref: 56] [Cited by in F6Publishing: 75] [Article Influence: 56.0] [Reference Citation Analysis]
12 Chong WC, Chellappan DK, Shukla SD, Peterson GM, Patel RP, Jha NK, Eri RD, Dua K, Tambuwala MM, Shastri MD. An Appraisal of the Current Scenario in Vaccine Research for COVID-19. Viruses 2021;13:1397. [PMID: 34372603 DOI: 10.3390/v13071397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Patel SP, Patel GS, Suthar JV. Inside the story about the research and development of COVID-19 vaccines. Clin Exp Vaccine Res 2021;10:154-70. [PMID: 34222129 DOI: 10.7774/cevr.2021.10.2.154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Li Z, Cao Y, Li Y, Zhao Y, Chen X. Vaccine delivery alerts innate immune systems for more immunogenic vaccination. JCI Insight 2021;6:144627. [PMID: 33690222 DOI: 10.1172/jci.insight.144627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Ullah S, Al-sehemi AG, Klemeš JJ, Saqib S, Gondal SMA, Saqib S, Arshad A, Saqib H, Mukhtar A, Ibrahim M, Asif S, Bokhari A. A Review of the Progress of COVID-19 Vaccine Development. Düzce Tıp Fakültesi Dergisi 2021. [DOI: 10.18678/dtfd.890089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dash P, Mohapatra S, Ghosh S, Nayak B. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. Front Pharmacol 2020;11:590154. [PMID: 33815095 DOI: 10.3389/fphar.2020.590154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Rani D, Nayak B, Srivastava S. Immunogenicity of gold nanoparticle-based truncated ORF2 vaccine in mice against Hepatitis E virus. 3 Biotech 2021;11:49. [PMID: 33457173 DOI: 10.1007/s13205-020-02573-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li Z, Zhao Y, Li Y, Chen X. Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines (Basel) 2021;9:75. [PMID: 33494477 DOI: 10.3390/vaccines9020075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Fatemi F, Hassani Nejad Z, Siadat SER. Vaccine Development and Immune Responses in COVID-19: Lessons from the Past. COVID-19 2021. [DOI: 10.1007/978-981-16-3108-5_5] [Reference Citation Analysis]
20 Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Res. 2020;288:198114. [PMID: 32800805 DOI: 10.1016/j.virusres.2020.198114] [Cited by in Crossref: 430] [Cited by in F6Publishing: 301] [Article Influence: 215.0] [Reference Citation Analysis]
21 George PJ, Tai W, Du L, Lustigman S. The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation. Vaccines (Basel) 2020;8:E251. [PMID: 32471056 DOI: 10.3390/vaccines8020251] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
22 Zhao Y, Li Z, Zhu X, Cao Y, Chen X. Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface. Biomaterials 2020;249:120030. [PMID: 32315864 DOI: 10.1016/j.biomaterials.2020.120030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Wang S, Yang G, Nie J, Yang R, Du M, Su J, Wang J, Wang J, Zhu Y. Recombinant Erns-E2 protein vaccine formulated with MF59 and CPG-ODN promotes T cell immunity against bovine viral diarrhea virus infection. Vaccine 2020;38:3881-91. [PMID: 32280039 DOI: 10.1016/j.vaccine.2020.03.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]